Stoffel Elena M, Ford Beth, Mercado Rowena C, Punglia Darashana, Kohlmann Wendy, Conrad Peggy, Blanco Amie, Shannon Kristen M, Powell Mark, Gruber Stephen B, Terdiman Jonathan, Chung Daniel C, Syngal Sapna
Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Clin Gastroenterol Hepatol. 2008 Mar;6(3):333-8. doi: 10.1016/j.cgh.2007.12.014. Epub 2008 Feb 7.
BACKGROUND & AIMS: Clinical genetic testing can help direct cancer screening for members of Lynch syndrome families; however, there is limited information about family communication of genetic test results.
A total of 174 probands who had genetic testing for Lynch syndrome were enrolled through 4 US cancer genetics clinics. Subjects were asked whether they had disclosed their genetic test results to first-, second-, and third-degree relatives. Univariate and multivariate analyses were used to identify clinical and demographic factors associated with informing immediate and extended family of genetic test results.
One hundred seventy-one of 174 probands (98%; 95% confidence interval, 95%-100%) reported that they had disclosed their genetic test result to a first-degree relative. Communication of test results to other relatives occurred significantly less often, with only 109 of 162 (67%; 95% confidence interval, 59%-74%) subjects with second- or third-degree relatives sharing their results. Individuals with a pathogenic mutation were significantly more likely to inform distant relatives than were subjects with a negative or indeterminate test result (odds ratio, 2.49; 95% confidence interval, 1.14-5.40). Probands' age, sex, and cancer status did not influence communication of genetic test results. Lack of closeness and concerns that relatives would worry or not understand the implications of test results were the primary reasons for not sharing genetic test results.
Most individuals who undergo genetic testing for Lynch syndrome share their test results with first-degree family members; however, these results reach more distant relatives significantly less often. Interventions to improve communication of genetic test results to members of the extended family are necessary to provide optimal cancer prevention care to at-risk families.
临床基因检测有助于指导林奇综合征家族成员的癌症筛查;然而,关于基因检测结果的家族沟通方面的信息有限。
通过美国4家癌症遗传学诊所招募了总共174名接受林奇综合征基因检测的先证者。受试者被问及是否已将其基因检测结果告知一级、二级和三级亲属。采用单因素和多因素分析来确定与向直系和旁系亲属告知基因检测结果相关的临床和人口统计学因素。
174名先证者中有171名(98%;95%置信区间,95%-100%)报告称他们已将基因检测结果告知了一级亲属。将检测结果告知其他亲属的情况明显较少,在有二级或三级亲属的162名受试者中,只有109名(67%;95%置信区间,59%-74%)分享了他们的结果。与检测结果为阴性或不确定的受试者相比,携带致病突变的个体向远亲告知结果的可能性显著更高(优势比,2.49;95%置信区间,1.14-5.40)。先证者的年龄、性别和癌症状态并未影响基因检测结果的沟通。缺乏亲密感以及担心亲属会担心或不理解检测结果的含义是不分享基因检测结果的主要原因。
大多数接受林奇综合征基因检测的个体与一级家庭成员分享他们的检测结果;然而,这些结果传达给更远亲属的情况明显较少。有必要采取干预措施来改善向大家庭成员传达基因检测结果的情况,以便为有风险的家庭提供最佳的癌症预防护理。